Substance use disorder (SUD), also called Drug addiction, is a condition when a person’s use of alcohol and/or drug substances leads to impairment, such as health problems, disability or problems at work, school or home. Addiction represents the most severe form of this disorder.
The exact cause of substance use disorder is not known. A person's genes, the action of the drug, peer pressure, emotional distress, anxiety, depression, and environmental stress can all be factors. Many who develop a substance use problem have depression, attention deficit disorder, post-traumatic stress disorder, or another mental problem. A stressful or chaotic lifestyle and low self-esteem are also common.
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast 2030" reports delivers an in-depth understanding of the Substance (Drug) Abuse Market, historical and forecasted epidemiology, the pipeline insight as well as the Substance (Drug) Abuse market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Substance (Drug) Abuse Market Facts
According to the study conducted by Merikangas et al., (2012), the prevalence rates of both alcohol and drug dependence (1.3% and 1.8% respectively) are about one fourth the magnitude of abuse (5.2% and 7.1%, respectively). Taken together, the lifetime prevalence rates of substance use disorders was 6.5% for alcohol and 8.9% for illicit drugs.
According to the study conducted by Polak et al., (2015), SUD belongs to the class of externalizing behaviors that are generally more common among men than women.
Substance (Drug) Abuse Market Analysis
The Substance (Drug) Abuse market analysis section of the report helps to build the detailed comprehension of the historic, current and forecasted Substance (Drug) Abuse market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Substance (Drug) Abuse market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Substance (Drug) Abuse Epidemiology Forecast
The Substance (Drug) Abuse epidemiology section covers insights about historical and current Substance (Drug) Abuse patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Substance (Drug) Abuse Pipeline Analysis and Key Companies
The Substance (Drug) Abuse Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Substance (Drug) Abuse market or expected to get launched in the market during the study period. The analysis covers the Substance (Drug) Abuse market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key companies in the Substance (Drug) Abuse market includes:
Omeros Corp.
InterveXion Therapeutics
KemPharm
MediciNova
And many others.
For more details on Substance (Drug) Abuse Market Insights, Epidemiology, and Pipeline Analysis visit: https://www.delveinsight.com/report-store/substance-drug-abuse-market